A recent study has identified certain regulatory variants linked to genetic risk for major depressive disorder in a GWAS, which include hippocampal transcription factors enriched for ZMIZ1, a zinc finger co-activator that increases ligand-dependent transcription of the androgen receptor and promotes androgen receptor sumoylation required for androgen receptor function [124]. The gene discussed is ZMIZ1; the disease is major depressive disorder.